Literature DB >> 24460739

Granulocyte colony-stimulating factor-producing lung cancer and acute respiratory distress syndrome.

Ryota Inokuchi1, Haruki Manabe, Fumihito Ohta, Kensuke Nakamura, Susumu Nakajima, Naoki Yahagi.   

Abstract

Granulocyte colony-stimulating factor (G-CSF)-producing lung cancers are known to cause extreme leukocytosis. However, acute respiratory distress syndrome (ARDS) caused by G-CSF-producing lung cancer is extremely rare. We present a case of G-CSF-producing lung cancer with marked leukocytosis, which rapidly led to severe ARDS after the patient developed pneumonia. The present case suggests that extreme leukocytosis may easily lead to ARDS, triggered by infection. Thus, G-CSF-producing lung cancer with marked leukocytosis should be carefully monitored before surgery and during treatment.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  ARDS; G-CSF; large-cell carcinoma; leukocytosis; lung cancer

Mesh:

Substances:

Year:  2014        PMID: 24460739     DOI: 10.1111/crj.12111

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  3 in total

1.  Blockade of indoleamine 2,3-dioxygenase reduces mortality from peritonitis and sepsis in mice by regulating functions of CD11b+ peritoneal cells.

Authors:  Masato Hoshi; Yosuke Osawa; Hiroyasu Ito; Hirofumi Ohtaki; Tatsuya Ando; Manabu Takamatsu; Akira Hara; Kuniaki Saito; Mitsuru Seishima
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

2.  The complex lipid, SPPCT-800, reduces lung damage, improves pulmonary function and decreases pro-inflammatory cytokines in the murine LPS-induced acute respiratory distress syndrome (ARDS) model.

Authors:  Peter P Sordillo; Andrea Allaire; Annie Bouchard; Dan Salvail; Sebastien M Labbe
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 3.  Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.

Authors:  Vijay K Singh; Patricia L P Romaine; Victoria L Newman; Thomas M Seed
Journal:  Expert Opin Ther Pat       Date:  2016-09-09       Impact factor: 6.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.